RU93012915A - COMPOSITION FOR CONDUCTING PHOTODYNAMIC THERAPY OF ONCOLOGICAL DISEASES - Google Patents

COMPOSITION FOR CONDUCTING PHOTODYNAMIC THERAPY OF ONCOLOGICAL DISEASES

Info

Publication number
RU93012915A
RU93012915A RU93012915/14A RU93012915A RU93012915A RU 93012915 A RU93012915 A RU 93012915A RU 93012915/14 A RU93012915/14 A RU 93012915/14A RU 93012915 A RU93012915 A RU 93012915A RU 93012915 A RU93012915 A RU 93012915A
Authority
RU
Russia
Prior art keywords
photodynamic therapy
composition
oncological diseases
preparations
radiation
Prior art date
Application number
RU93012915/14A
Other languages
Russian (ru)
Other versions
RU2051680C1 (en
Inventor
Л.Г. Томилова
Ю.Г. Хусед
В.Б. Лошенков
В.М. Подгаецкий
Б.А. Константинов
И.И. Парфенов
Ф.Х. Камилов
И.Г. Рахматуллин
Original Assignee
Совместное предприятие "Башкорт"
Filing date
Publication date
Application filed by Совместное предприятие "Башкорт" filed Critical Совместное предприятие "Башкорт"
Priority to RU93012915A priority Critical patent/RU2051680C1/en
Priority claimed from RU93012915A external-priority patent/RU2051680C1/en
Application granted granted Critical
Publication of RU2051680C1 publication Critical patent/RU2051680C1/en
Publication of RU93012915A publication Critical patent/RU93012915A/en

Links

Claims (1)

Состав относится к лазерной медицине и может быть использован в препаратах внешнего и внутреннего действия при лечении онкологических заболеваний методом фотодинамической терапии при возбуждении препаратов лазерным излучением. Состав изготовлен на основе раствора редкоземельных и переходных элементов структурной формулы
Figure 00000001
где М - ион редкоземельного или переходного элемента, Рс - замещенный фталоцианин, где где′ - t - Bu, перфтор t - Bu, Me - в органическом растворителе при концентрации 2 • 10- 4 - 2 • 10- 3 моль/л, растворитель - остальное. Предлагаемое изобретение может обеспечить широкое внедрение метода фотодинамической терапии в медицинскую практику и расширение области применения этого метода для поздних стадий заболевания и глубокорасположенных опухолей за счет использования для возбуждения препаратов ближнего инфракрасного излучения неодимовых и более длинноволнового излучения других лазеров.The composition relates to laser medicine and can be used in preparations of external and internal action in the treatment of oncological diseases by the method of photodynamic therapy when the preparations are excited by laser radiation. The composition is made on the basis of a solution of rare earth and transition elements of the structural formula
Figure 00000001
where M is a rare-earth or transition element ion, Pc is a substituted phthalocyanine, where where ′ is t - Bu, perfluoro t is Bu, Me is in an organic solvent at a concentration of 2 • 10 - 4 - 2 • 10 - 3 mol / l, solvent - the rest. The present invention can provide a widespread introduction of the method of photodynamic therapy in medical practice and the expansion of the field of application of this method for advanced stages of the disease and deep-seated tumors due to the use of neodymium and longer-wave radiation of other lasers to excite near-infrared radiation.
RU93012915A 1993-03-10 1993-03-10 Composition for photodynamic therapy performing RU2051680C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93012915A RU2051680C1 (en) 1993-03-10 1993-03-10 Composition for photodynamic therapy performing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93012915A RU2051680C1 (en) 1993-03-10 1993-03-10 Composition for photodynamic therapy performing

Publications (2)

Publication Number Publication Date
RU2051680C1 RU2051680C1 (en) 1996-01-10
RU93012915A true RU93012915A (en) 1996-05-10

Family

ID=20138453

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93012915A RU2051680C1 (en) 1993-03-10 1993-03-10 Composition for photodynamic therapy performing

Country Status (1)

Country Link
RU (1) RU2051680C1 (en)

Similar Documents

Publication Publication Date Title
Esipova et al. Oxyphor 2P: a high-performance probe for deep-tissue longitudinal oxygen imaging
US6493570B1 (en) Method for improved imaging and photodynamic therapy
Park et al. Theranostic probe based on lanthanide‐doped nanoparticles for simultaneous in vivo dual‐modal imaging and photodynamic therapy
NO995181L (en) Acid labile and enzymatically cleavable dye compounds for near-infrared light diagnostics and for therapy
RU95101843A (en) 4-amino-1-piperidylbenzoyl guanidines
RU92016479A (en) APPLICATION 5,10,15,20-TETRAKIS (4-CARBOXYPHENYL) PORPHINE FOR DETECTION AND TREATMENT OF LUNG CANCER
CN105199732A (en) Near-infrared long-afterglow material with dual functions of bioimaging and photo-thermal treating and preparation method of near-infrared long-afterglow material
Lee et al. Oxidation of guanine in G, GG, and GGG sequence contexts by aromatic pyrenyl radical cations and carbonate radical anions: relationship between kinetics and distribution of alkali-labile lesions
DE60034031D1 (en) HIGH-RESOLUTION IMAGING USING OPTICALLY TRANSPARENT PHOSPHORIC COMPLEXES
RU93012915A (en) COMPOSITION FOR CONDUCTING PHOTODYNAMIC THERAPY OF ONCOLOGICAL DISEASES
Makhadmeh et al. Photodynamic application of protoporphyrin IX as a photosensitizer encapsulated by silica nanoparticles
DK0470188T3 (en) New magnetic resonance imaging agents
Cubeddu et al. Tumor detection in mice by measurement of fluorescence decay time matrices
SE9103837D0 (en) FLUORESCENSE DIAGNOSIS OF CANCER USING DELTA-AMINOLEVULIC ACID
RU2007140384A (en) REINFORCING AGENT FOR RADIATION THERAPY, INCLUDING A PYRIDINE DERIVATIVE AS AN ACTIVE INGREDIENT
Alekseev et al. Luminescent diagnostics of skin defects in the near-infrared range
BR0312114A (en) Methods and contrast agents useful for quantifying nitric oxide
Reeßing et al. A photocleavable contrast agent for light-responsive MRI
Alexandrova et al. In vitro investigation on cytotoxic activity of TS4PP [5, 10, 15, 20-tetra (4-sulfophenyl) porphyrin]
Satpathy et al. Versatile Nanoplatforms for Bioimaging and Therapy Using Upconversion Nanoparticles
Delario Methods of enhancing roentgen-ray action
RU2051680C1 (en) Composition for photodynamic therapy performing
RU95109874A (en) Heterocyclylhydroxybenzoylguanidines, method of their synthesis, pharmaceutical composition containing thereof and method of its preparing
Chelliah et al. Irradiation of myoglobin by intense, ultrashort laser pulses
RU27489U1 (en) RADIATING TREATMENT TERMINAL